A snapshot of hot biotech in Latin America

October 31, 2016 Erin Righetti

According to a report from Deloitte, healthcare spending in Latin America is projected to increase 4.6 percent on average annually between 2014 and 2018, as pharmaceutical spending grows an average of 6.1 percent annually. Latin America has an emerging life science market and therefore holds many opportunities for internationally minded organizations. For a preview of Latin America biotech companies you will meet at Biolatam™ life science partnering event in Puerto Rico this November 29–30, read this post by LaBiotech.eu.

 

 

Read more...

About the Author

Erin Righetti

Editor-in-Chief, Insight

Follow on Twitter More Content by Erin Righetti
Previous Article
Steps for choosing the right development partner
Steps for choosing the right development partner

Guest post by Laura Marquis, Vice President and Global Head, Emerging Biopharma, QuintilesIMS™ As I prepare...

Next Article
Aging R&D takes center stage at BIO-Europe®
Aging R&D takes center stage at BIO-Europe®

Guest post by John Carroll, Co-Founder and Editor of Endpoints   Last spring I was fascinated to read a sto...